![](/img/cover-not-exists.png)
Bevacizumab may differentially improve ovarian cancer outcome in patients with proliferative and mesenchymal molecular subtypes
Kommoss, Stefan, Winterhoff, Boris, Oberg, Ann, Konecny, Gottfried E., Wang, Chen, Riska, Shaun M, Fan, Jian-Bing, Maurer, Matthew J., April, Craig, Shridhar, Viji, Kommoss, Friedrich, du Bois, AndreaLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-2196
Date:
February, 2017
File:
PDF, 510 KB
english, 2017